This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Synthego Corporation. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations of Jared Carlson-Stevermer
Introduction
Jared Carlson-Stevermer is an accomplished inventor based in Burlingame, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of CRISPR technology. With a total of 2 patents, his work is paving the way for advancements in genetic engineering.
Latest Patents
Jared's latest patents include "Stabilized CRISPR complexes" and "Systems and methods for modulating CRISPR activity." The first patent provides polynucleotides and CRISPR effector proteins that are covalently bound together in a CRISPR complex. This innovation allows for modifications to enhance the efficacy of target binding and cleavage. The second patent focuses on polynucleotides designed to bind to CRISPR effector proteins, enabling the tuning of their activity through various modifications.
Career Highlights
Jared is currently employed at Synthego Corporation, where he continues to push the boundaries of CRISPR technology. His work is instrumental in developing more effective gene-editing tools that can have a profound impact on medicine and agriculture.
Collaborations
Some of Jared's notable coworkers include Reed Kelso and Sahil Joshi. Their collaborative efforts contribute to the innovative environment at Synthego Corporation.
Conclusion
Jared Carlson-Stevermer's contributions to CRISPR technology exemplify the potential of modern biotechnology. His patents reflect a commitment to advancing genetic engineering, which could lead to groundbreaking applications in various fields.